Review: taking Miralax and Zofran together


Summary

Drug interactions are reported among people who take Miralax and Zofran together. This review analyzes the effectiveness and drug interactions between Miralax and Zofran. It is created by eHealthMe based on reports of 1,880 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Miralax and Zofran >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Miralax

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. (latest outcomes from Miralax 14,389 users)

Zofran

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. (latest outcomes from Zofran 25,842 users)

On Aug, 22, 2016

1,880 people who take Miralax, Zofran are studied.


Number of reports submitted per year:

Miralax and Zofran drug interactions.

Drug effectiveness over time:

Miralax:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 50.0% - (2 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Zofran:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Miralax:
  • female: 20.0% - (1 of 5 people)
  • male: 33.0% - (1 of 3 people)
Zofran:
  • female: 20.0% - (1 of 5 people)
  • male: 33.0% - (1 of 3 people)

Drug effectiveness by age:

Miralax:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)
Zofran:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • abdominal pain
  • febrile neutropenia
  • neutropenia
  • blood bilirubin increased
  • mucosal inflammation
  • pneumonitis
  • constipation
  • acute respiratory distress syndrome
  • nausea
  • hypotension
1 - 6 months:
  • acute respiratory distress syndrome
  • headache
  • pneumonitis
  • blood bilirubin increased
  • constipation
  • febrile neutropenia
  • hypersensitivity
  • mucosal inflammation
  • pain
  • pneumonia
6 - 12 months:
  • anxiety
  • dizziness
  • insomnia
  • small intestinal obstruction
  • abdominal pain
  • arthropathy
  • asthenia
  • atelectasis
  • bone lesion
  • cholecystitis
1 - 2 years:
  • apnoeic attack
  • atrial septal defect
  • cardiac murmur
  • drug exposure during pregnancy
  • failure to thrive
  • gastrooesophageal reflux disease
  • glossoptosis
  • heart disease congenital
  • laryngomalacia
  • micrognathia
2 - 5 years:
  • acute respiratory distress syndrome
  • coeliac artery compression syndrome
  • constipation
  • drug dependence
  • hepatic necrosis
  • pneumonia
  • anaemia
  • diabetic gastroparesis
  • drug withdrawal syndrome
  • abdominal pain upper
not specified:
  • nausea
  • pain
  • fatigue
  • vomiting
  • dyspnoea
  • anxiety
  • pyrexia
  • constipation
  • anaemia
  • back pain

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • dyspnoea
  • anxiety
  • vomiting
  • constipation
  • fatigue
  • pyrexia
  • back pain
  • anaemia
male:
  • pain
  • nausea
  • fatigue
  • asthenia
  • vomiting
  • dehydration
  • diarrhoea
  • pyrexia
  • anaemia
  • anxiety

Most common drug interactions by age *:

0-1:
  • constipation
  • decreased appetite
  • diabetes insipidus
  • hyponatraemia
  • muscle spasms
  • myoclonic epilepsy
  • pain
  • dehydration
  • hypernatraemia
  • vomiting
2-9:
  • febrile neutropenia
  • pyrexia
  • mucosal inflammation
  • neutropenia
  • abdominal pain
  • respiratory distress
  • vomiting
  • constipation
  • epistaxis
  • haemoglobin decreased
10-19:
  • hypotension
  • blood bilirubin increased
  • vomiting
  • abdominal pain
  • pyrexia
  • mucosal inflammation
  • febrile neutropenia
  • nausea
  • pneumonitis
  • headache
20-29:
  • pain
  • nausea
  • injury
  • pulmonary embolism
  • abdominal pain
  • headache
  • anxiety
  • cholecystitis chronic
  • dizziness
  • dyspnoea
30-39:
  • nausea
  • constipation
  • pain
  • dyspnoea
  • pneumonia
  • vomiting
  • fatigue
  • abdominal pain
  • acute respiratory distress syndrome
  • asthenia
40-49:
  • nausea
  • dyspnoea
  • pain
  • vomiting
  • back pain
  • anxiety
  • fatigue
  • pyrexia
  • constipation
  • injury
50-59:
  • pain
  • anxiety
  • dyspnoea
  • arthralgia
  • fatigue
  • anaemia
  • oedema peripheral
  • constipation
  • osteonecrosis of jaw
  • injury
60+:
  • fatigue
  • nausea
  • asthenia
  • pain
  • vomiting
  • anaemia
  • diarrhoea
  • constipation
  • pneumonia
  • anxiety

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Miralax and Zofran?

Can you answer these questions?

More questions for: Miralax, Zofran

You may be interested in these reviews

More reviews for: Miralax, Zofran

On eHealthMe, Miralax (polyethylene glycol 3350) is often used to treat constipation. Zofran (ondansetron hydrochloride) is often used to treat nausea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.